Pfizer has been granted patent in India by the Indian Patent Office for its vaccine Prevenar 13, used for protection against pneumonia. The grant of the patent means that Indian pharmaceutical firms will not be able to make the vaccine.
The development has, however, been decried by Medicines Sans Frontiers (MSF), an international medical humanitarian organization saying granting patent on the vaccine could impact its availability.
Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.
